Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JPMA to Finalize GL for Disclosure of Funds Offered to Medical Institutions
January 31, 2011
- PMDA to Transfer GMP Compliance Inspection Power Earlier to Prefectures
January 31, 2011
- Sanofi-aventis Signs R&D Collaboration Agreements with UCSF
January 31, 2011
- JACDS to Clarify Its Stance on Points Granted for Copayments of Dispensing Fees
January 31, 2011
- Roche Diagnostics Obtains Approval for HER2 Gene Amplification Kit
January 31, 2011
- No. of Prescriptions Filled by GROWELL Up Sharply Due to Point Granting
January 31, 2011
- Takara Bio to Globally Develop HF10 Licensed from M's Science
January 31, 2011
- Xyzal Ranked No. 1 in GP Market: RepTrack Survey
January 31, 2011
- Takeda, Kyoto Univ. to Collaborate for CNS Drug Discovery
January 31, 2011
- aRigen Licenses Novel Anti-MRSA to GCC in South Korea
January 31, 2011
- Kyowa Kirin Licenses AMG827 from Amgen
January 31, 2011
- Tokuhon to Launch 2 Adhesive NSAIDs in China
January 31, 2011
- Daiichi Sankyo, ArQule Begin PIII Trial of ARQ197
January 31, 2011
- Barclays Revises Alfresa's Business Forecasts Downward
January 31, 2011
- Daiichi Sankyo Healthcare Launches Switch OTC Version of Loxoprofen
January 31, 2011
- Toho HD Starts Operating Joint Venture in China
January 31, 2011
- Japan's 1st Direct OTC Drug Based on Western Herbal Medicine Approved
January 31, 2011
- Nomura Securities Highlights CNS Drugs
January 31, 2011
- EC Calls For Submission of Patent Settlement Agreements
January 31, 2011
- Sales of Ethical Drugs Up 3.8% in November 2010
January 31, 2011
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…